Literature DB >> 7696124

Prospects for induction of tolerance in renal transplantation.

A M Krensky1, C Clayberger.   

Abstract

Immunological tolerance is the ultimate goal of transplantation immunobiology. Current therapies involve nonspecific immunosuppression with concomitant risks for infection, malignancy, and drug-specific side effects. By inducing specific immune unresponsiveness to the graft it should be possible to maintain transplants without the need for chronic drug administration and without the risk of nonspecific immunosuppression. This review highlights recent progress in the understanding of immunological tolerance, with special attention to the long-term prospects for successful induction of tolerance in renal transplant patients.

Entities:  

Mesh:

Year:  1994        PMID: 7696124     DOI: 10.1007/bf00869120

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  74 in total

Review 1.  Mechanism of activation and tolerance induction in b lymphocytes.

Authors:  W O Weigle; B J Skidmore
Journal:  Transplant Rev       Date:  1975

2.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

Review 3.  The induction of tolerance to alloantigens using HLA-based synthetic peptides.

Authors:  A M Krensky; C Clayberger
Journal:  Curr Opin Immunol       Date:  1994-10       Impact factor: 7.486

Review 4.  Effect of adjuvants on orally administered antigens.

Authors:  R J Genco; R Linzer; R T Evans
Journal:  Ann N Y Acad Sci       Date:  1983-06-30       Impact factor: 5.691

5.  Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.

Authors:  A I Lazarovits; J Rochon; L Banks; D J Hollomby; N Muirhead; A M Jevnikar; M J White; P L Amlot; L Beauregard-Zollinger; C R Stiller
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

6.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

7.  HILDA/LIF, G.CSF, IL-1 beta, IL-6, and TNF alpha production during acute rejection of human kidney allografts.

Authors:  G Blancho; J F Moreau; D Chabannes; L Chatenoud; J P Soulillou
Journal:  Transplantation       Date:  1993-09       Impact factor: 4.939

8.  Induction of TNF alpha and TNF beta gene expression in rat cardiac transplants during allograft rejection.

Authors:  T T Pizarro; K Malinowska; E J Kovacs; J Clancy; J A Robinson; L A Piccinini
Journal:  Transplantation       Date:  1993-08       Impact factor: 4.939

9.  Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A.

Authors:  S Nisco; P Vriens; G Hoyt; S C Lyu; F Farfan; P Pouletty; A M Krensky; C Clayberger
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

10.  Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells.

Authors:  K E Truitt; C M Hicks; J B Imboden
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  1 in total

Review 1.  Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.

Authors:  B Fulton; A Markham
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.